Clincosm LogoSign in Get a demo

al amyloidosis

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

    Not yet recruiting
    • AL Amyloidosis
    • Bone Marrow Biopsy
    • +4 more
    • Scottsdale, Arizona
    • +2 more
    Jun 2, 2023

    Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

    Active, not recruiting
    • Multiple Myeloma
    • AL Amyloidosis
    • Siltuximab
    • The M.D. Anderson Symptom Inventory (MDASI)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

    Active, not recruiting
    • AL Amyloidosis
    • Palo Alto, California
    • +2 more
    Dec 6, 2022

    AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

    Recruiting
    • AL Amyloidosis
    • Belantamab mafodotin
    • Limoges, France
    • +5 more
    Sep 26, 2022

    Outcome of Patients With Systemic AL Amyloidosis in Europe

    Completed
    • AL Amyloidosis
      • Wien, Austria
      • +12 more
      Sep 26, 2022

      AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

      Not yet recruiting
      • AL Amyloidosis
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Aug 16, 2022

      AL Amyloidosis Trial in France (Isatuximab)

      Recruiting
      • AL Amyloidosis
      • Amiens, France
      • +14 more
      Aug 9, 2022

      AL Amyloidosis Trial in Worldwide (CAEL-101, Placebo, cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen)

      Recruiting
      • AL Amyloidosis
      • Phoenix, Arizona
      • +101 more
      Aug 4, 2022

      AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

      Recruiting
      • AL Amyloidosis
      • daratumumab and pomalidomide
      • Catanzaro, Italy
      • +2 more
      Aug 3, 2022

      AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

      Not yet recruiting
      • AL Amyloidosis
      • Amyloidosis
      • Belantamab mafodotin 2.5 mg/kg (6 weeks)
      • +4 more
      • Stanford, California
      • +3 more
      Jul 25, 2022

      AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

      Not yet recruiting
      • AL Amyloidosis
      • Venetoclax Oral Tablet, 200 mg
      • +9 more
      • New York, New York
        New York Presbyterian Hospital/Columbia University Irving Medica
      Jul 11, 2022

      Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

      Suspended
      • Amyloid
      • +2 more
      • New York, New York
        Weill Cornell Medicine - Multiple Myeloma Center
      May 17, 2022

      AL Amyloidosis Trial in Pavia

      Recruiting
      • AL Amyloidosis
        • Pavia, Italy
          Fondazione IRCCS Policlinico San Matteo
        May 4, 2022

        AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

        Recruiting
        • AL Amyloidosis
        • Orange, California
        • +5 more
        May 3, 2022

        Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis Trial ([18F]florbetaben)

        Not yet recruiting
        • Cardiac Amyloidosis
        • +2 more
        • (no location specified)
        Apr 22, 2022

        AL Amyloidosis Trial in Beijing

        Recruiting
        • AL Amyloidosis
          • Beijing, China
            Peking Union Medical College Hospital
          Apr 20, 2022

          Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

          Recruiting
          • Multiple Myeloma
          • +2 more
          • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
          • Detroit, Michigan
            Barbara Ann Karmanos Cancer Institute
          Apr 12, 2022

          AL Amyloidosis Trial in Worldwide (Melphalan-Flufenamide (Melflufen), Dexamethasone)

          Terminated
          • AL Amyloidosis
          • Boston, Massachusetts
          • +8 more
          Mar 10, 2022

          Hereditary Transthyretin Amyloidosis

          Recruiting
          • Amyloidosis
          • +6 more
            • Cleveland, Ohio
              Cleveland Clinic
            Mar 11, 2022

            AL Amyloidosis Trial in United States (Ixazomib, Dexamethasone)

            Recruiting
            • AL Amyloidosis
            • Boston, Massachusetts
            • +7 more
            Jan 21, 2022

            Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

            Recruiting
            • Amyloidosis
            • AL Amyloidosis
            • Denver, Colorado
            • +1 more
            Jan 18, 2022

            AL Amyloidosis Trial in Boston (daratumumab)

            Completed
            Has Results
            • AL Amyloidosis
            • Boston, Massachusetts
              Boston Medical Center
            Apr 15, 2021

            AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing

            Enrolling by invitation
            • AL Amyloidosis
            • Plasma Cell Dyscrasia
              • Nanjing, Jiangsu, China
                National Clinical Research Center of Kidney Diseases, Jinling Ho
              Jan 26, 2021